Literature DB >> 21902813

Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings.

Xiaoqiang Xiang1, Janne T Backman, Pertti J Neuvonen, Mikko Niemi.   

Abstract

Cholesterol 7α-hydroxylase (CYP7A1) is the rate-limiting enzyme of bile acid production in human beings, and organic anion-transporting polypeptide 1B1 (OATP1B1) may influence bile acid hepatic uptake and cholesterol and bile acid synthesis rate. Our purpose was to investigate the effects of gender and CYP7A1 and SLCO1B1 polymorphisms on the fasting plasma concentrations of bile acids, bile acid synthesis marker and total cholesterol in a Finnish population. Fasting plasma concentrations of 16 endogenous bile acids, their synthesis marker (7α-hydroxy-4-cholesten-3-one) and total cholesterol were measured in 243 samples from 143 healthy volunteers. The volunteers were genotyped for 6 haplotype-tagging single-nucleotide polymorphisms (SNPs) of CYP7A1 and two functionally relevant SNPs in SLCO1B1. The mean plasma concentrations of chenodeoxycholic acid, glycochenodeoxycholic acid, ursodeoxycholic acid and glycoursodeoxycholic acid were 61-111% higher in men than in women (P ≤ 0.001). Accordingly, the mean concentration of total bile acids was 51% higher in men than in women (P = 0.001). The CYP7A1 rs8192879 and rs1023652 SNPs were associated with deoxycholic acid and hyodeoxycholic acid concentrations, respectively, but the associations were not significant after correction for multiple testing. None of the six CYP7A1 SNPs was associated with the plasma concentrations of cholesterol or 7α-hydroxy-4-cholesten-3-one. SLCO1B1 genotype was associated with total plasma cholesterol concentration only, but the association was not significant after correction for multiple testing. In general, the gender contributes substantially more to variation in fasting plasma bile acid concentrations than CYP7A1 or SLCO1B1 polymorphism do. Common genetic variability in CYP7A1 is unlikely to play a significant role in cholesterol metabolism and bile acid homeostasis under normal physiological conditions.
© 2011 The Authors. Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21902813     DOI: 10.1111/j.1742-7843.2011.00792.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  8 in total

Review 1.  Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.

Authors:  Kyunghee Yang; Cen Guo; Jeffrey L Woodhead; Robert L St Claire; Paul B Watkins; Scott Q Siler; Brett A Howell; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

2.  Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population.

Authors:  Eda Sezer; Birsen Can Demirdöğen; Şeref Demirkaya; Giray Bulut; Merve Akkulak; Emre Evin; Orhan Adalı
Journal:  Neurol Sci       Date:  2021-09-21       Impact factor: 3.307

3.  CYP7A1 gene polymorphism located in the 5' upstream region modifies the risk of coronary artery disease.

Authors:  Tomasz Iwanicki; Anna Balcerzyk; Pawel Niemiec; Tomasz Nowak; Anna Ochalska-Tyka; Jolanta Krauze; Sylwia Kosiorz-Gorczynska; Wladyslaw Grzeszczak; Iwona Zak
Journal:  Dis Markers       Date:  2015-04-06       Impact factor: 3.434

Review 4.  The influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis.

Authors:  Taylor Phelps; Erin Snyder; Erin Rodriguez; Hailey Child; Pamela Harvey
Journal:  Biol Sex Differ       Date:  2019-11-27       Impact factor: 5.027

Review 5.  Bile Acid Signaling in Neurodegenerative and Neurological Disorders.

Authors:  Stephanie M Grant; Sharon DeMorrow
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

6.  Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults--Results from the Cross-Sectional KarMeN Study.

Authors:  Lara Frommherz; Achim Bub; Eva Hummel; Manuela J Rist; Alexander Roth; Bernhard Watzl; Sabine E Kulling
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

7.  Identification of Glycochenodeoxycholate 3-O-Glucuronide and Glycodeoxycholate 3-O-Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers.

Authors:  Mikko Neuvonen; Päivi Hirvensalo; Aleksi Tornio; Brian Rago; Mark West; Sarah Lazzaro; Sumathy Mathialagan; Manthena Varma; Matthew A Cerny; Chester Costales; Ragu Ramanathan; A David Rodrigues; Mikko Niemi
Journal:  Clin Pharmacol Ther       Date:  2020-10-18       Impact factor: 6.875

Review 8.  Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.

Authors:  Agata Mulak
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.